QCPUA-100

SECTION 2: Hazards identification

OSHA Hazards Physical State: Liquid OSHA/HCS Status: This material is classified as hazardous under OSHA Hazard Communication Standard 29 CFR 1910.1200.

Precautionary statements

Do not breathe dust/fumes/gas/mist/vapors/spray. Wear protective gloves. Wear respiratory protection. IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Immediately call a POISON CENTER or doctor/physician.

2.1 Classification of the substance or mixture

HEALTH, Respiratory or Skin Sensitization, 1 Respiratory HEALTH, Respiratory or Skin Sensitization, 1 Skin HEALTH, Skin Corrosion/Irritation, 2 HEALTH, Carcinogenicity, 2 HEALTH, Serious Eye Damage/Eye Irritation, 2 A HEALTH, Specific Target Organ Toxicity – Single Exposure, 3 HEALTH, Acute Toxicity, 5 Oral

Signal word

DANGER

Hazard statements

May cause allergy or asthma symptoms or breathing difficulties if inhaled May cause an allergic skin reaction Causes skin irritation Suspected of causing cancer Causes serious eye irritation May cause drowsiness or dizziness May be harmful if swallowed Not Otherwise Classified or not Covered by GHS

Principle Routes of Exposure

Eyes, ingestion, inhalation, skin Target Organs: Respiratory system, skin, eyes Inhalation: At room temperature, MDI vapors are minimal due to low vapor pressure. However, heating, spraying, foaming, or otherwise mechanically dispersing (drumming, venting or pumping) operations may generate vapor or aerosol concentrations sufficient to cause irritation or other adverse effects. Excessive exposure may cause irritation of the eyes, upper respiratory tract and lungs. Severe overexposure may lead to pulmonary edema. May cause respiratory sensitization with asthma-like symptoms in susceptible individuals. MDI concentrations below the exposure guidelines may cause allergic respiratory reactions in individuals already sensitized. Symptoms may include coughing, dryness of throat, headache, nausea, difficult breathing and a feeling of tightness in the chest. Effects may be delayed. Impaired lung function (decreased ventilator capacity) has been associated with overexposure to isocyanates. Chronic: As a result of previous repeated overexposures or a single large dose, certain individuals develop isocyanate sensitization (chemical asthma) or tissue injury in the upper respiratory tract. Animal tests indicate skin contact alone may also lead to allergic respiratory reaction. These effects may be permanent. Any person developing asthmatic reaction or sensitization should be removed from further exposure. Skin Contact: Product is a skin sensitizer. Causes irritation with symptoms of reddening, itching and swelling. Prolonged or repeated exposure can cause skin irritation, reddening, dermatitis, and in some individuals, sensitization. Skin contact may result in allergic skin reactions or respiratory sensitization, but is not expected to result in absorption of amounts sufficient to cause other adverse effects. May stain skin. Cured material is difficult to remove. Eye Contact: As a liquid, vapor, aerosol or dust, may cause irritation, inflammation, and/or damage to sensitive eye tissue. Symptoms include reddening, tearing, stinging and swelling. May cause corneal injury. Prolonged contact may cause conjunctivitis. Ingestion: Single dose oral toxicity is considered to be extremely low. Can result in irritation and corrosive action in the mouth, stomach tissue and digestive tract. Symptoms can include nausea, vomiting, sore throat, abdominal pain and diarrhea. Ingestion is not an applicable route of entry for intended use. HMIS (USA) Health 2; Flammability 1;

Physical hazards

1; Personal Protection X Insignificant 0; Slight 1; Moderate 2; High 3; Extreme 4 The customer is responsible for determining the PPE code for this material. See toxicological information (Section 11). General Information: Read the entire SDS for a more thorough evaluation of the hazards.